Dr. Brinda Balakrishnan, M.D., Ph.D.
Equibles does not estimate personal net worth.
About Dr. Brinda Balakrishnan, M.D., Ph.D.
Earlier roles on record: Board Member at Aurinia Pharmaceuticals Inc. (AUPH) until September 12, 2024. Aurinia Pharmaceuticals Inc. reported in an 8-K filed September 12, 2024 that Dr. Brinda Balakrishnan, M.D., Ph.D. resigned as Director. Aurinia Pharmaceuticals Inc. reported in an 8-K filed September 12, 2024 that Dr. Brinda Balakrishnan, M.D., Ph.D. resigned as director, effective September 9, 2024.
“The Board has accepted the conditional resignations of Daniel G. Billen, Ph.D., R. Hector MacKay-Dunn, J.D., and Brinda Balakrishnan, M.D., Ph.D., who received less than majority support at the Meeting.”
“the Board, following the deliberation process outlined in the Company's Majority Voting Policy, determined (i) to accept the resignations of Dr. Billen, Mr. MacKay-Dunn, and Dr. Balakrishnan, effective September 9, 2024”
Affiliation history
-
2021-06-14–2024-09-12